UK drug policy shows limited impact on novel psychoactive substances
Short excerpt below. Click through to read at the original source.
Novel psychoactive substances (NPS) are chemically engineered substances designed to mimic the effects of traditional controlled drugs such as opioids, stimulants, and cannabinoids. These compounds pose significant health risks due to their unpredictable potency and toxicity. There is little evidence to suggest NPS are manufactured within the U.K. China has long been identified as the […]